BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2530207)

  • 1. Insurance company to pay for AZT.
    J Ark Med Soc; 1989 Nov; 86(6):247. PubMed ID: 2530207
    [No Abstract]   [Full Text] [Related]  

  • 2. Physicians not fazed by AZT guidelines.
    Macilwain C
    Nature; 1993 Jul; 364(6433):93. PubMed ID: 8321294
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA notifications. FDA approves generic AZT.
    AIDS Alert; 2007 Jul; 22(7):79. PubMed ID: 17763553
    [No Abstract]   [Full Text] [Related]  

  • 4. To AZT or not to AZT.
    Stern A; Dickinson E
    JEMS; 1993 Oct; 18(10):29-30. PubMed ID: 10129825
    [No Abstract]   [Full Text] [Related]  

  • 5. Report on a 3-year follow-up zidovudine (AZT) treatment in a group of HIV-positive patients with congenital clotting disorders.
    Sartori MT; Mares M; Zerbinati P; Stocco D; Girolami A
    Haematologia (Budap); 1994; 26(1):17-27. PubMed ID: 7959371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Education needed after AZT failure.
    Nurs Stand; 1993 Apr 7-13; 7(29):6. PubMed ID: 8499278
    [No Abstract]   [Full Text] [Related]  

  • 7. [Open questions about HIV/AZT].
    Garattini S
    Riv Inferm; 1994; 13(2):104-6. PubMed ID: 7863189
    [No Abstract]   [Full Text] [Related]  

  • 8. 3TC/AZT: just another combination.
    GMHC Treat Issues; 1995 Dec; 9(12):2. PubMed ID: 11362997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of zidovudine related mutations in the reverse transscriptase gene of HIV after switching therapy.
    Falkensammer B; El Attal R; Müllauer B; Sarcletti M; Parson W; Dierich MP; Stoiber H
    Eur J Med Res; 2002 Sep; 7(9):379-86. PubMed ID: 12435615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Federal task force advises on zidovudine use during pregnancy.
    Am J Hosp Pharm; 1994 Dec; 51(24):3020-1. PubMed ID: 7856618
    [No Abstract]   [Full Text] [Related]  

  • 11. AZT benefits HIV-positive asymptomatic people: new hope, new challenges.
    Lewis A
    AIDS Educ Prev; 1989; 1(4):347. PubMed ID: 2641256
    [No Abstract]   [Full Text] [Related]  

  • 12. Zidovudine and lamivudine: results of phase III studies.
    Staszewski S
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S57. PubMed ID: 8595510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Researchers are rethinking role of AZT in drug therapy.
    AIDS Policy Law; 1995 Oct; 10(18):11. PubMed ID: 11362821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progression of HIV infection halved: early AZT therapy--advantage confirmed in a large European-Australian study].
    Toeller V
    Pharm Unserer Zeit; 1993 Nov; 22(5-6):263. PubMed ID: 8121928
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA notifications. Zidovudine approved for pediatric use.
    AIDS Alert; 2009 Sep; 24(9):105. PubMed ID: 19928325
    [No Abstract]   [Full Text] [Related]  

  • 16. AZT in pregnant women with HIV: risks and benefits.
    Doyle VB
    Neonatal Netw; 1995 Mar; 14(2):62-3. PubMed ID: 7746241
    [No Abstract]   [Full Text] [Related]  

  • 17. AZT trials and tribulations.
    Crouch RA; Arras JD
    Hastings Cent Rep; 1998; 28(6):26-34. PubMed ID: 9868608
    [No Abstract]   [Full Text] [Related]  

  • 18. CDC study supports AZT use after occupational injury. Centers for Disease Control and Prevention.
    Cotton D
    AIDS Clin Care; 1996 Feb; 8(2):18. PubMed ID: 11363061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New guidelines issued for occupational exposures.
    AIDS Policy Law; 1998 May; 13(10):10. PubMed ID: 11365445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Finding suggests AZT therapy may help prevent occupational HIV infection.
    AIDS Alert; 1995 Apr; 10(4):45-7. PubMed ID: 11362245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.